The Doctors are in: Peripheral arterial disease, a silent but serious health ... 
Florida Times-Union
Peripheral arterial disease, or PAD, is a rather common disease process affecting well over 12 million Americans. But it is a serious disease; even when completely silent and asymptomatic, it carries a risk of death much higher than most cancers.
DMC Cardiovascular Institute participates in Avinger's CONNECT II Global ... MarketWatch (press release)

all 9 news articles » 

Lantheus Appoints New Member to Its Board of Directors 
MarketWatch (press release)
... ABLAVAR(R) (gadofosveset trisodium), a first-in-class magnetic resonance agent indicated for the evaluation of aortoiliac occlusive disease in adults with known or suspected peripheral vascular disease; TechneLite(R) (Technetium Tc99m Generator), ...

and more » 

ENABLER-P Balloon Catheter System offers alternative to surgical revascularization 
News-Medical.net
A new balloon catheter system could advance the endovascular approach to treating obstructed arteries in the leg, offering an alternative to surgical revascularization. Peripheral artery disease affects about 12 to 14 percent of the general population, ...

 

DMC Cardiovascular Institute In New PAD Clinical Trial 
CBS Local
... Institute announced Wednesday that it will participate in Connect II, a global clinical trial conditionally approved by the FDA that gives physicians access to Ocelot, a new imaging technology tool to fight Peripheral Arterial Disease.

and more » 

Lantheus Medical Imaging Announces Appointment of Alexander E. Kuta, Ph.D., as ... 
MarketWatch (press release)
... ABLAVAR(R) (gadofosveset trisodium), a first-in-class magnetic resonance agent indicated for the evaluation of aortoiliac occlusive disease in adults with known or suspected peripheral vascular disease, TechneLite(R) (Technetium Tc99m Generator), ...

and more » 

Cardiovascular Systems Reports Fiscal 2012 Third-Quarter Financial Results 
MarketWatch (press release)
The Stealth 360 deg (TM) PAD System, Diamondback 360(R) PAD System and Predator 360(R) PAD System are percutaneous orbital atherectomy systems indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and ...

and more » 

Next-generation transcatheter aortic valve looks good in 30-day registry data 
TheHeart.Org
Usually, if the transfemoral route was available, that's the route they chose, but some patients had too much peripheral disease or other complications that made the transfemoral approach too difficult, Wendler said. Wendler pointed out that for ...

and more » 

Fifteen-year experience with minimally invasive approach for reoperations ... 
The Journal of Thoracic and Cardiovascular Surgery
14,19,20,22,23 Our practice has been to screen selectively patients with a history of peripheral vascular disease, and we have extended such screening to elderly patients in recent years. Stroke as a complication has been more reproducibly linked to ...

 

U.S. Patents Awarded to Inventors in Arizona (May 1) 
Targeted News Service (subscription)
... cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis, peripheral artery occlusive disease, endothelial dysfunction, ...

and more » 

CR Bard's CEO Discusses Q1 2012 Results - Earnings Call Transcript 
Seeking Alpha
Sales in our peripheral PTA line increased 8%, with about 400 basis points coming from the addition of the products in the ClearStream acquisition, with over half of those sales outside the United States. Within PTA, our Chronic Total Occlusion, ...